Invention Grant
- Patent Title: Heterocyclic inhibitors of MCT4
-
Application No.: US16222949Application Date: 2018-12-17
-
Publication No.: US11292767B2Publication Date: 2022-04-05
- Inventor: Kenneth Mark Parnell , John McCall , Donna Romero
- Applicant: Vettore, LLC
- Applicant Address: US CA San Francisco
- Assignee: Vettore, LLC
- Current Assignee: Vettore, LLC
- Current Assignee Address: US CA San Francisco
- Agent Dennis A. Bennett; Lauren L. Stevens; Cynthia Hathaway
- Main IPC: C07D231/14
- IPC: C07D231/14 ; C07D231/56 ; A61P35/00 ; C07D207/24 ; C07C59/01 ; C07D205/02 ; C07D401/04 ; C07D403/04 ; C07D403/10 ; C07D403/14 ; C07D405/04 ; C07D405/12 ; C07D409/04 ; C07D413/04 ; C07D417/04 ; C07D213/12 ; A61K45/06 ; A61K31/415 ; C07D403/06 ; C07D405/06 ; C07D405/14
Abstract:
Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I: Methods of inhibition MCT4 activity in a human or animal subject are also provided.
Public/Granted literature
- US20190112275A1 HETEROCYCLIC INHIBITORS OF MCT4 Public/Granted day:2019-04-18
Information query
